Hosted on MSN50m
Piper Sandler Initiates Coverage of Avalo Therapeutics (AVTX) with Overweight RecommendationFintel reports that on February 28, 2025, Piper Sandler initiated coverage of Avalo Therapeutics (NasdaqCM:AVTX) with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback